🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Determination the efficacy of daily oral treatment with laquinimod 0.6 mg c...
Status
Completed
Location
Teva Investigational Site 1076
Start Date
2007-11-13
Trial ID
NCT00509145
Treatments Being Tested
This is a single center, randomized, double blind, placebo controlled, 2-wa...
Status
Completed
Location
Teva Investigational Site 32415
Start Date
2014-02
Trial ID
NCT02085863
Treatments Being Tested
The study aims to evaluate the safety and clinical effect of daily oral tre...
Status
Completed
Location
Teva Investigational Site 1363
Start Date
2010-10-04
Trial ID
NCT01085084
Treatments Being Tested
This is a multinational, multicenter, randomized, double-blind, parallel-gr...
Status
Terminated
Location
Teva Investigational Site 382
Start Date
2005-12-07
Trial ID
NCT00745615
Treatments Being Tested
To make laquinimod 0.6 mg available for all subjects who completed the plac...
Status
Terminated
Location
Teva Investigational Site 1267
Start Date
2010-05-27
Trial ID
NCT01047319
Treatments Being Tested
This Phase 2 study is intended to serve as a proof of concept for potential...
Status
Completed
Location
Teva Investigational Site 12966
Start Date
2015-01-12
Trial ID
NCT02284568
Treatments Being Tested
This is a Phase 1 randomized, double-masked, placebo-controlled study perfo...
Status
Completed
Location
Clinical trial center at Medical University Vienna
Start Date
2021-12-09
Trial ID
NCT05187403
Treatments Being Tested
Teva is developing laquinimod tablets as a new oral treatment for MS. Laqui...
Status
Completed
Location
Multiple Locations
Start Date
2005-03
Trial ID
NCT00349193
Treatments Being Tested
The study aims to compare the effect of daily oral treatment of laquinimod ...
Status
Completed
Location
Teva Investigational Site 1267
Start Date
2008-04-24
Trial ID
NCT00605215
Treatments Being Tested
The LION Study is a prospective, single-center phase 1 clinical trial to ev...
Status
Recruiting
Location
Spencer Center for Vision Research at the Byers Eye Institute
Start Date
2024-05-03
Trial ID
NCT06161415
Treatments Being Tested